Characterization of chronic myeloid leukemia stem cells

Though tyrosine kinase inhibitors have redefined the care of chronic myeloid leukemia (CML), these agents have not proved curative, likely due to resistance of the leukemia stem cells (LSC). While a number of potential therapeutic targets have emerged in CML, their expression in the LSC remains larg...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gerber, Jonathan M., Qin, Lu, Kowalski, Jeanne, Smith, B. Douglas, Griffin, Constance A., Vala, Milada S., Collector, Michael I., Perkins, Brandy, Zahurak, Marianna, Matsui, William, Gocke, Christopher D., Sharkis, Saul J., Levitsky, Hyam I., Jones, Richard J.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3010878/
https://ncbi.nlm.nih.gov/pubmed/21132730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21915
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires